Mercator Medical S.A.
MRC.WA · WSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | PLN 408 | PLN 433 | PLN 417 | PLN 447 |
| - Cash | PLN 132 | PLN 119 | PLN 126 | PLN 123 |
| + Debt | PLN 24 | PLN 24 | PLN 5 | PLN 5 |
| Enterprise Value | PLN 300 | PLN 337 | PLN 296 | PLN 329 |
| Revenue | PLN 145 | PLN 143 | PLN 148 | PLN 144 |
| % Growth | 1.3% | -3% | 2.2% | – |
| Gross Profit | PLN 27 | PLN 34 | PLN 44 | PLN 41 |
| % Margin | 18.4% | 24% | 29.5% | 28.5% |
| EBITDA | PLN 13 | PLN 2 | PLN 27 | PLN 0 |
| % Margin | 9.1% | 1.1% | 18.3% | 0.1% |
| Net Income | PLN 5 | -PLN 9 | PLN 30 | PLN 21 |
| % Margin | 3.3% | -6.5% | 20.2% | 14.5% |
| EPS Diluted | 0.51 | -1.01 | 3.22 | 2.24 |
| % Growth | 150.5% | -131.4% | 43.7% | – |
| Operating Cash Flow | PLN 47 | PLN 4 | -PLN 30 | -PLN 44 |
| Capital Expenditures | -PLN 12 | -PLN 20 | -PLN 7 | -PLN 5 |
| Free Cash Flow | PLN 35 | -PLN 16 | -PLN 36 | -PLN 48 |